Friday, November 15, 2024
HomeTagsSkin diseases

skin diseases

DermBiont Raises $28 Million and Acquires Chromaderm to Expand Targeted Topical Therapeutics in Development

DermBiont, a clinical-stage biotechnology company developing targeted topical therapeutics that address the root causes of skin diseases, announced that it has raised a $28...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics